GSK3β also interacts with PP2Ac to regulate NF-κB activity, and the novel GSK3β inhibitor 5n has been found to protect against AKI through PP2Ac-dependent mechanisms [64]. The gene discussed is GSK3B; the disease is acute kidney injury.